The Patent Finder
US

mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES

US 9,956,271 In force
OverviewFamilyAssignmentsSources & methods

Term ends Nov 29, 2031 · High confidence

Filed May 18, 2015 as application 14/714,871 · Granted May 1, 2018
Base term, 20 years from filing
Today
20 years from filing
2011 2031
Clock starts
Nov 29, 2011
Term ends
Nov 29, 2031
Granted
May 1, 2018
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,143,758, to Nov 29, 2031. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 29, 2011, when application 13/306,781, the earliest non-provisional in its chain, was filed (this one was filed May 18, 2015)Nov 29, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,143,758)resolves to Nov 29, 2031, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 29, 2031High confidence

This family

US 8,853,377In force
Nov 2031
Nov 2031
US 9,061,021In force
no later than Nov 2031
no later than Nov 2031
US 9,956,271this patent
Nov 2031
Nov 2031
US 11,135,274In force
Nov 2031
Nov 2031
Application 17/465,287Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 4, 2016
Reel 37399, frame 782
Guild, Braydon Charles; Heartlein, Michael; Derosa, FrankShire Human Genetic Therapies, Inc.Assignment of Assignor's Interest
Apr 6, 2017
Reel 42177, frame 32
Shire Human Genetic Therapies, Inc.Rana Therapeutics, Inc.Assignment of Assignor's Interest
Jul 20, 2017
Reel 43267, frame 165
Rana Therapeutics, Inc.Translate Bio, Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited